E-Mail
WASHINGTON, DC - MAY 20, 2021 - As Congress considers legislation to reform prescription drug pricing, a new analysis conducted by the West Health Policy Center and released by its Council for Informed Drug Spending Analysis (CIDSA) estimates that the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) could result in hundreds of billions of dollars in lower commercial health insurance costs by 2030.These savings would come from a $195 billion reduction in employer costs and $98 billion in savings for workers.
The non-profit, non-partisan West Health Policy Center engaged the actuarial firm Milliman, to analyze the impact of the legislation on stakeholders. Using Milliman s analysis and other data sources West Health Policy Center researchers then quantified the dollar impact on employee and employer costs.
As Congress considers legislation to reform prescription drug pricing, a new analysis conducted by the West Health Policy Center and released by its Council for Informed Drug Spending Analysis (CIDSA) estimates that the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) could result in hundreds of billions of dollars in lower commercial health insurance costs by 2030.
Bioprinted Hydrogel Material
The 3D bioprinted cartilage is based on a specially designed hydrogel - a jelly-like raw material - that is mixed with human cells harvested from the patient. This mixture of the hydrogel and organic material is then printed in the specific shape of the target nose cartilage based on images captured with 3D imaging. Over several weeks, the fabricated material is cultured in a lab - under controlled conditions - to become fully functional cartilage. It takes a lifetime to make cartilage in an individual, while this method takes about four weeks. So you still expect that there will be some degree of maturity that it has to go through, especially when implanted in the body, explains Adetola Adesida, a co-author of the study and a surgery professor at the university s Faculty of Medicine & Dentistry, in a press release from the University of Alberta. She adds that functionally speaking, it also does the things that natural cartilage does.
Patients hit with surprise medical bills paid ER docs 10 times more than others healthcaredive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcaredive.com Daily Mail and Mail on Sunday newspapers.
Below is Alston & Bird’s
Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, CMS issued its proposed FY 2022 payment updates for inpatient psychiatric and rehabilitation facilities, hospice, and skilled nursing facilities. Read more about the updates and other news below.
I. Regulations, Notices & Guidance
On April 5, 2021, the Food and Drug Administration (FDA) issued guidance entitled,
Development of Abbreviated New Drug Applications During the COVID-19 Pandemic Questions and Answers Guidance for Industry. FDA is issuing this guidance to provide general recommendations to prospective applicants and applicants of abbreviated new drug applications (ANDAs) related to generic drug product development and regulatory submissions in the form of